LATEST NEWS AND ARTICLES
From events, scientific articles to PR, you will find here all our latest news.
- News
Meet us at the CHU Healthtech Connexion Day on December 8–9 in Bordeaux and discover our 3D bioprinter in action through live demos.
- News
We were delighted to take part in this year’s International Conference on Biofabrication, where we showcased our Next-Generation Bioprinting (NGB) platform through live demos!
- News
7th TERMIS World Congress in Seattle, USA, to discuss the latest advancements in tissue engineering and regenerative medicine !
- Press release
Poietis and HVD Life Sciences are pleased to announce the signature of their collaboration for the distribution of Poietis’ Next-Generation Bioprinting (NGB) platform designed for translational research in Austria and Germany.
- News
Poietis's NGB platform, offers unparalleled precision in 3D bioprinting, addressing key challenges in organ-on-chip (OoC) development.
- News
We are proud to be partner in the 4-Deep Brain Reconstruction (4-DBR) initiative, a Horizon European Innovation Council (EIC) Pathfinder Open project aimed at revolutionizing the treatment of neurodegenerative disorders.
- News
The French Society for Stem Cell Research (@FSSCR) recently concluded a three-day conference, drawing over 300 participants deeply engaged in the latest stem cell research developments.
- Press release
The installation of the NGB (Next-Generation Bioprinting) robotic bioprinting platform developed by Poietis in the Advanced Therapy Medicinal Product (ATMP) manufacturing area of the Hôpital de la Conception represents a world premiere and opens up very promising perspectives in regenerative medicine. The objective is now to start the first clinical trial of a 3D printed human tissue.
- Press release
Poietis, 4D Bioprinting company, announces formation of Scientific Advisory Board (SAB) and appointment of two first prominent Scientists in Regenerative Medicine: Dr. Gurtner and Dr. May
- Press release
Poietis, leading bioprinting company, and the « Assistance Publique – Hôpitaux de Marseille » (AP-HM) announced today that they have entered into a partnership through the signature the 20th of January of a clinical research collaboration contract on a bioprinted tissue engineering product.
Do you want to know more about NGB platform?